Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksREDX.L Share News (REDX)

  • There is currently no data for REDX

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK DIRECTOR DEALINGS SUMMARY: Braveheart Buys Stake In RMS From Brown

Wed, 01st Jul 2020 17:15

(Alliance News) - The following is a round-up of share dealings by London-listed company directors and managers announced on Tuesday and Wednesday and not separately reported by Alliance News:

----------

Remote Monitored Systems PLC - London-based majority owner of GyroMetric Systems Ltd, which provides digital monitoring and safeguarding systems for rotating shafts on wind turbines - Braveheart Investment Group PLC buys 119.6 million shares from Executive Director Trevor Brown at 0.275 pence, worth GBP329,003, on Tuesday. Brown is chief executive officer of Braveheart, and payment for the RMS shares is in new Braveheart shares issued to Brown. Following the transaction, Braveheart owns 18.1% of RMS, and Brown has no interest. Brown now has a 24.8% stake in Braveheart. RMS owns 58% of GyroMetric and Braveheart owns 19.5%. Brown will remain on the RMS board to represent Braveheart.

----------

Savills PLC - London-based estate agent - James Sparrow, CEO of Savills UK & EMEA, sells 4,096 shares at GBP8.33, worth GBP34,100, on Friday last week. Still holds 58,475 shares.

----------

Babcock International Group PLC - London-based engineering services for defence - Chair Ruth Cairnie and associate buy 10,000 shares in total at GBP3.12 and GBP3.15, worth GBP31,333, on Wednesday.

----------

Qinetiq Group PLC - Farnborough, Hampshire-based security and defence contractor - Non-Executive Director Susan Searle buys 10,000 shares at GBP3.0244, worth GBP30,244, on Wednesday.

----------

Walker Greenbank PLC - Denham, Buckinghamshire-based interior furnishings - Non-Executive Director Christopher Rogers buys 52,500 shares at 37p, worth GBP19,425, on Tuesday. Now has 75,000 shares.

----------

Renew Holdings PLC - Leeds-based engineering services for infrastructure - Non-Executive Director Shatish Dasani and wife Dina buy 10,000 shares total at 444p, worth GBP44,400, on Tuesday. Dasani now interested in 15,000 shares.

----------

Staffline Group PLC - Nottingham-based recruitment and training firm - Three directors buy GBP70,857 in shares on Tuesday. Executive Chair Ian Lawson buys 131,577 shares at 39.00p, worth GBP51,315. Interim Chief Financial Officer Daniel Quint buys 25,320 shares at average 39.49p, worth GBP9,209. Non-Executive Director Richard Thomson buys 25,857 shares at average 39.96p, worth GBP10,333.

----------

Solid State PLC - Redditch, Worcestershire-based electronic components - Finance Director Peter James buys 2,520 shares at GBP5.95, worth GBP14,994. Now has 3,204 shares. Matthew Richards, managing director of subsidiary Steatite Ltd, buys 2,900 shares at GBP5.91, worth GBP17,126. Now has 10,375 shares. Both on Tuesday.

----------

ECSC Group PLC - Bradford-based cybersecurity firm - CEO Ian Mann buys 29,827 shares at average 67p, worth GBP19,984, on Wednesday. Now has 2.3 million shares, a 23% stake.

----------

Redx Pharma PLC - Macclesfield-based cancer and fibrosis drugs - Non-Executive Chair Iain Ross buys 215,870 shares at average 18.94p, worth GBP40,886, on Tuesday. Non-Executive Director Peter Presland buys 118,849 shares at 25p, worth GBP29,712, also on Tuesday. Both purchases are their only holdings.

----------

Trackwise Designs PLC - Tewkesbury, Gloucestershire-based printed circuit technology - Non-Executive Director Charles Cattaneo buys 10,000 shares at 86p, worth GBP8,600, on Tuesday. The shares are his only holding.

----------

UIL Ltd - closed-end Bermuda-incorporated investment company - Non-Executive Director Stuart Bridges buys 6,080 shares at 180p, worth GBP10,944, on Wednesday.

----------

By Tom Waite; thomaslwaite@alliancenews.com

Copyright 2020 Alliance News Limited. All Rights Reserved.

More News
24 Feb 2016 09:44

Redx Pharma Makes Progress On Gonorrhoea Treatment And Other Drugs

Read more
20 Jan 2016 10:00

Redx Pharma Continues Pipeline Progressing In Maiden Results

Read more
13 Jan 2016 16:00

Earnings, Trading Statements Calendar - Week Ahead

Read more
4 Jan 2016 08:35

New Redx director brings scientific, commercial expertise

(ShareCast News) - Redx announced the appointment of a non-executive director on Monday, with Dr Bernhard Kirschbaum joining the firm's board immediately. The AIM-listed self-described drug discovery and development company said Dr Kirschbaum was bringing with him more than 25 years experience in ph

Read more
3 Dec 2015 07:54

Redx Pharma Identifies New Cancer Drug Development Candidate

Read more
6 Nov 2015 09:42

DIRECTOR DEALINGS: Redx Pharma Chairman, Non-Executives Buy Shares

Read more
1 Oct 2015 07:36

Redx Pharma Says It Made "Good Progress" In Second Half

Read more
3 Sep 2015 08:00

Redx Pharma And Horizon Discovery Collaborating On Cancer Research

Read more
22 Jun 2015 14:17

Redx Pharma enjoys good progress during first-half

Two months after its admission to AIM, Redx Pharma said its first-half results were in line with expectations thanks to progress on potential MRSA drugs. Losses before tax rose 60.5% to £3.26m due to a decrease in grant funding and operating expenses increased 5% to £5.48m. The drug discovery and d

Read more
22 Jun 2015 08:35

Redx Pharma Positive For Full Year, Loss Widens In Maiden Interims

Read more
2 Jun 2015 11:13

Redx Pharma cheers with progress on potential MRSA drug

Redx shares jumped on the news it has reached the pre-clinical development stage with a new anti-infective compound designed to tackle MRSA, the bacteria that causes potentially lethal infections in humans. The pharmaceutical firm said the progress marked a "significant milestone" for its commercial

Read more
2 Jun 2015 07:00

Redx Pharma Progresses To Pre-Clinical Stage With MRSA Treatment

Read more
26 May 2015 07:43

Redx Pharma Identifies Second Drug Development Candidate

Read more
14 May 2015 09:41

Redx Pharma To Launch New Immunology Subsidiary

Read more
14 May 2015 08:55

Redx Pharma Says Third Paper On Antimicrobial Resistance Published

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.